ASBMB to host summit on the sustainability of the research enterprise
Training periods and trainee populations have increased over the past decade despite stagnant federal funding, resulting in a research workforce that is expanding beyond the capacity of the available funding to support it. A variety of groups have written reports describing these problems in great detail and made a series of recommendations to fix them.
The Public Affairs Advisory Committee of the ͵ÅÄ͵¿ú and ͵ÅÄ͵¿ú Biology has also been working on issues concerning the sustainability of the . This work culminated in in the Proceedings of the National Academy of Sciences in September. This article eight recommendations made by a majority of reports addressing the significant structural problems of the enterprise.
On Feb. 4–5, the ͵ÅÄ͵¿ú and ͵ÅÄ͵¿ú Biology will take the first major step toward implementing these recommendations by of leaders committed to change (see below). For the past two months, summit participants have worked to flesh out ideas and identify action items related to research funding, enhancing training and optimizing the workforce.
The author of this article (Chris Pickett, policy analyst at the ASBMB and lead staff member for the event) will conduct a phone briefing at 2:30 p.m. Feb. 5 summarizing the major outcomes of the summit. Email bcorb@asbmb.org for call-in information.
Participants in the 2016 ASBMB Sustainability Summit
- Bruce Alberts, University of California, San Francisco and Rescuing Biomedical Research
- Margaret Anderson, FasterCures and the Melanoma Research Alliance
- Jeremy Berg, University of Pittsburgh
- Cynthia Fuhrmann, University of Massachusetts Medical School
- Howard Garrison, Federation of American Societies for Experimental Biology
- Matthew Gentry, University of Kentucky
- Kenneth Gibbs, National Institutes of Health
- Judith Greenberg, National Institutes of Health
- Susanna Greer, American Cancer Society
- Louis Justement, University of Alabama at Birmingham
- Terri Goss Kinzy, Robert Wood Johnson Medical School
- Alan Leshner, American Association for the Advancement of Science
- Jon Lorsch, National Institutes of Health
- Kay Lund, National Institutes of Health
- Susan Marqusee, University of California, Berkeley
- C. Robert Matthews, University of Massachusetts Medical School
- Kenneth Maynard, Takeda Pharmaceuticals
- Gary McDowell, Tufts University
- Sharon Milgram, National Institutes of Health
- Mary O’Riordan, University of Michigan Medical School
- Greg Petsko, Weill Cornell Medicine
- John Randell, American Academy of Arts and Sciences
- Phil Ryan, National Institutes of Health
- Paula Stephan, Georgia State University
- Wes Sundquist, University of Utah
- Michael Teitelbaum, Harvard Medical School
- Shirley Tilghman, Princeton University and Rescuing Biomedical Research
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Policy
Policy highlights or most popular articles
Applied research won’t flourish without basic science
Three senior figures at the US National Institutes of Health explain why the agency remains committed to supporting basic science and research.
ASBMB weighs in on NIH reform proposal
The agency must continue to prioritize investigator-initiated, curiosity-driven basic research, society says.
ASBMB seeks feedback on NIH postdoc training questions
The National Institutes of Health takes steps toward addressing concerns about support caps, a funding mechanism and professional development.
5 growing threats to academic freedom
From educational gag orders to the decline of tenure-track positions, academic freedom in the United States has been worsening in recent years.
Will Congress revive the China Initiative?
The 2018 program to counter economic espionage raised fears about anti-Asian discrimination and discouraged researchers.
The sweeping impact of the Supreme Court’s Chevron reversal
Repealing the 40-year-old doctrine throws laws on climate, conservation, health, technology and more into doubt.